Champions Oncology, Inc.

NasdaqCM:CSBR Stock Report

Market Cap: US$102.8m

Champions Oncology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:CSBR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Jan 24BuyUS$6,500Daniel MendelsonIndividual1,000US$6.50
11 Jan 24BuyUS$12,540Daniel MendelsonIndividual2,000US$6.27
10 Jan 24BuyUS$18,577Daniel MendelsonIndividual2,944US$6.31
09 Jan 24BuyUS$18,750Daniel MendelsonIndividual3,000US$6.25
08 Jan 24BuyUS$6,150Daniel MendelsonIndividual1,000US$6.15
05 Jan 24BuyUS$30,540Daniel MendelsonIndividual5,000US$6.12
03 Jan 24BuyUS$2,915Daniel MendelsonIndividual500US$5.83

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CSBR?
Owner TypeNumber of SharesOwnership Percentage
Hedge Funds882,5816.44%
Institutions1,649,60112%
General Public3,452,33425.2%
Individual Insiders3,578,99426.1%
VC/PE Firms4,135,39330.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 74.64% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.7%
Battery Ventures L.P.
2,421,673US$18.2m0%1.42%
12.5%
New Enterprise Associates, Inc.
1,713,720US$12.9m0%0.66%
7.02%
Joel Ackerman
962,134US$7.2m12.3%no data
6.44%
West Elk Capital, LLC
882,581US$6.6m-19.3%29.65%
6.27%
Ronnie Morris
858,878US$6.4m0%no data
5.6%
David Sidransky
767,043US$5.8m0%no data
5.42%
Norman Pessin
742,161US$5.6m0%no data
5.15%
Tocqueville Asset Management LP
705,214US$5.3m3.01%0.08%
2.24%
The Vanguard Group, Inc.
307,002US$2.3m0%no data
1.45%
Daniel Mendelson
198,625US$1.5m0%no data
0.88%
Renaissance Technologies LLC
119,991US$900.5k-2.12%no data
0.85%
BlackRock, Inc.
116,191US$872.0k0.1%no data
0.47%
Geode Capital Management, LLC
65,064US$488.3k3.14%no data
0.42%
Morgan Stanley, Investment Banking and Brokerage Investments
57,800US$433.8k34.1%no data
0.35%
Goldman Sachs Group, Investment Banking and Securities Investments
48,413US$363.3k-30.1%no data
0.3%
Northern Trust Global Investments
41,071US$308.2k1.5%no data
0.29%
HighTower Advisors, LLC
39,308US$295.0k14.6%no data
0.22%
Acadian Asset Management LLC
30,697US$230.4k0%no data
0.22%
Scott Tobin
30,000US$225.2k0%no data
0.2%
BNY Asset Management
26,749US$200.7k0%no data
0.19%
State Street Global Advisors, Inc.
26,553US$199.3k0%no data
0.18%
Bank of America Corporation, Asset Management Arm
25,308US$189.9k0.14%no data
0.11%
Philip Breitfeld
14,638US$109.9k0%no data
0.089%
Cambridge Investment Research Advisors, Inc.
12,252US$92.0k0%no data
0.088%
Mesirow Financial Investment Management, Inc.
12,000US$90.1k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 08:57
End of Day Share Price 2024/12/20 00:00
Earnings2024/10/31
Annual Earnings2024/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Champions Oncology, Inc. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Paul BienstockB. Riley Wealth
Matthew HewittCraig-Hallum Capital Group LLC
Paul KnightJanney Montgomery Scott LLC